5-(2-ethyl-phenyl)-3-(3-methoxy-phenyl)-1H-[1,2,4]triazole (DL-111-IT) and related compounds induce apoptotic patterns in cultures of human tumor cell lines

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 4, 2003, Pages 348-357

  Burattini, S ^a   Luchetti, F ^a   Battistelli, M ^a   Della Felice, M ^a   Papa, S ^a   Piersanti, G ^a   Tarzia, G ^a   Falcieri, Elisabetta ^a,b  

^a UNIVERSITY OF URBINO   (Italy)

^b CNR   (Italy)

Author keywords

DNA ladder; Electron microscopy; Triazoles; Tumor cell lines

Indexed keywords

2 (3 METHOXYPHENYL) 5,6 DIHYDRO [1,2,4]TRIAZOLO[5,1 A]ISOQUINOLINE; 2 BIPHENYL 4 YLIMIDAZO[2,1 A]ISOQUINOLINE; 2 PHENYL 5H IMIDAZO[2,3 A]ISOINDOLE; 2 PHENYL 5H [1,2,4]TRIAZOLO[5,1 A]ISOINDOLE; 3 (2 ETHYLPHENYL) 5 (3 METHOXYPHENYL) 1H 1,2,4 TRIAZOLE; 5 (2 ETHYLPHENYL) 3 (3 ETHOXYPHENYL) 1H [1,2,4]TRIAZOLE; 5 (2 ETHYLPHENYL) 3 (3 METHOXYPHENYL) 1H [1,2,4]TRIAZOLE; 5 (2 HYDROXYMETHYLPHENYL) 3 (3 METHOXYPHENYL) 1H [1,2,4]TRIAZOLE; ANTINEOPLASTIC AGENT; DNA; L 10488; L 10503; L 11730; L 14510; L 14608; ORNITHINE DECARBOXYLASE INHIBITOR; POLYAMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL STRAIN HL 60; CHORION; CONTROLLED STUDY; DEPLETION; DNA DETERMINATION; DRUG RESPONSE; DRUG SENSITIVITY; ELECTRON MICROSCOPY; ELECTROPHORESIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NEUROBLAST; TUMOR CELL CULTURE;

EID: 1842423587     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Lerner LJ, Galliani G, Carminati P, Mosca MC. Antifertility drugs. Novel nonhormonal compounds that inhibit prostaglandin metabolism. Nature 1975; 256: 130-2.
2. Lerner LJ, Gil-Ad I. Effect of a novel anti-fertility compound on plasma prolactin, gonadotropins and progesterone levels in the pregnant rat. Res Steroid 1979; 8: 225-7.
3. Galliani G, Lerner LJ, Caramel C, Maraschin R, Nani S, Nava A. Pregnancy termination in dogs with novel nonhormonal compounds. Studies of 2-(3-Ethoxy-phenyl)-5,6-dihydro-s-triazole[5,1-a]isoquinoline (DL204-IT). Arzneim Forsch / Drug Res 1982; 32: 123-7.
4. Galliani G, Omodei-Salè A. Pregnancy termination in dogs with nonhormonal compounds: Evaluation of selected derivatives. J Small Animal Pract 1982; 23: 295-300.
5. Assandri A, Omodei-Salè A, Galliani G. A new class of nonhormonal contragestational agents: Pharmacodynamic-pharmacokinetic relationships. Rev Drug Metab Drug Interact 1982; 4: 237-61.
6. Galliani G, Assandri A, Gallico L, et al. A new nonhormonal pregnancy-terminating agent. Contraception 1981; 23: 163-80.
7. Assandri A, Perazzi A, Ferrari P, et al. Metabolic pathways of the contragestational agent 3-(2- Ethylphenyl)-5-(-3-methoxyphenyl)-1H-1,2,4-triazole (DL-111-IT) in the rat. Xenobiotica 1984; 14: 429-43.
8. Omodei-Salè A, Consonni P, Galliani G. A new class of nonhormonal pregnancy-terminating agents. Synthesis and contragestational activity of 3,6-Diaryl-s-triazoles. J Med Chem 1983; 26: 1187-92.
9. Winters, Odasso G, Conti M, Tarzia G, Galliani G. Synthesis and pregnancy terminating activity of pyrazolo[1,5-a]indoles and -quinolines. Eur J Med Chem Chim Ther 1984; 19: 215-8.
10. Toja E, Omodei-Salè A, Cattaneo C, Galliani G. Synthesis and pregnancy terminating activity of 2-Arylimidazo[5,1-a]isoindoles and -indoles. Arzneim - Forsch / Drug Res 1983; 33: 1222.
11. Assandri A, Barone D, Omodei-Salè A, Galliani G. Lotrifen (Privaprol): The first nonhormonal agent for the control of pet overpopulation. Drugs of Today / Med Actual 1987; 23: 75-86.
12. Galliani G, Guzzi U, Tarzia G, Assandri A. 2-(1,1′-Biphenyl-4-yl)-1,2,4-triazolo[5,1-a]isoquinoline (L14105), a potential orally active contragestational agent for the bitch: Studies in the rat, hamster and dog. J Vet Pharmacol Therap 1986; 9: 246-53.
13. Galliani G, Assandri A, Lerner LJ, et al. DL 111, a new nonhormonal antifertility agent: Contragestational and kinetic profile in baboons. Contraception 1982; 26: 165-79.
14. Galliani G, Luzzani F, Colombo G, et al. On the mode of action of a new contragestational agent (DL-111-IT). Contraception 1986; 33: 263-83.
15. Yang Bo, Cao Lin, Gu Zhiping. Effects of DL-111-IT on decidua, PGs contents and uterine contractility in pregnant rats. Yaoxue Xuebao 2000; 35: 641-44, (CAN 134: 2902-24).
16. Shentu, JZ, Zhou HJ, He QJ, Wang LM, Fang RY. Effects of DL-111-IT or combined with RU486 on uterine polyamine biosynthesis in rats during early gestation. Contraception 2001; 63: 283-7.
17. Yang Bo, Zhou Hui-Jun, He Qiao-Jun, Fang Rui-Ying. Termination of early pregnancy in the mouse, rat and hamster with DL111-IT and RU486. Contraception 2000; 62: 211-6.
18. Rotello RJ, Lieberman RC, Lepoff RB, Gerschenson LE. Characterization of uterine epithelium apoptotic cell death and regulation by orogesterone and RU 486. Am J Pathol 1992; 140: 449-56.
19. Pecci A, Scholz A, Pelster D, Beato M. Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS. J Biol Chem 1997; 272: 11791-8.
20. Rueda BR, Hendry IR, Hendry WJ, Stormshak F, Slayden OD, Davis JS. Decreased progesterone levels and progesterone receptor antagonists promote apoptotic cell death in bovine luteal cells. Biol Reprod 2000; 62: 269-76.
21. Makrigiannakis A, Coukos G, Christofidou-Solomidou M, Montas S, Coutifaris C. Progesterone is an autocrine/paracrine regulator of human granulosa cell survival in vitro. Ann NY Acad Sci 2000; 900: 16-25.
22. Pegg AE, Poulin R, Coward JK. Use of aminopropyltransferase inhibitors and of non-metabolizable analogs to study polyamine regulation and function. Int J Biochem Cell Biol 1995; 27: 425-42.
23. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980 68: 251-306.
24. Cohen JJ. Programmed cell death in the immune system. Adv Immunol 1991; 50: 890-3.
25. Stefanelli C, Bonavita F, Stanic' I, et al. ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis. Biochem J 1997; 322: 909-17.
26. Falcieri E, Bassini A, Pierpaoli S, et al. Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec 2000; 253: 90-9.
27. Morris EJ, Geller HM. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase I: Evidence for cell cycle-independent toxicity. J Cell Biol 1996; 134: 757-70.
28. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7: 535-43.
29. Uckun FM. Rationally designed anti-mitotic agents with pro-apoptotic activity. Curr Pharm Design 2001; 7: 1627-39.
30. Simoni D, Tolomeo M. Retinoids, apoptosis and cancer. Curr Pharm Design 2001; 7: 1823-37.
31. Falcieri E, Luchetti F, Burattini S, Canonico B, Santi S, Papa S. Lineage-related sensitivity to apoptosis in human tumor cells undergoing hyperthermia. Histochem Cell Biol 2000; 113: 135-44.
32. Burattini S, Luchetti F, Canonico B, et al. Hyperthermia induces apoptosis in human tumor cells: A morpho-functional study. 4th Multinat Congr Electron Microsc, Veszprem (HU) 1999; 195.
33. Ho CK, Chi CW, Yu KJ, Wang SY. Tamoxifen-mediated anti-cellular effect against a choriocarcinoma cell line. Int J Oncol 1998; 12: 1171-6.
34. Martelli AM, Robuffo I, Bortul R, et al. Behavior of nucleolar proteins during the course of apoptosis in camptothecin-treated HL60 cells. J Cell Biochem 2000; 78: 264-77.
35. Boe R, Gjertsen BT, Vintermyr OK, Houge G, Lanotte M, Doskeland SO. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res 1991; 195: 237-46.
36. Renò F, Burattini S, Luchetti F, et al. Phospholipid rearrangement of apoptotic membrane does not depend on nuclear activity. Histochem Cell Biol 1998; 110: 467-76.
37. Luchetti F, Canonico B, Zamai L, et al. Apoptosis and expression of LDA-1 in human neuroblastoma SK-N-MC cell line. Europ J Histoch 2001; 45: 58.
38. Columbaro M, Gobbi P, Renò F, Santi S, Valmori A, Falcieri E. A multiple technical approach to the study of apoptotic cell micronuclei. Scanning 1998; 20: 541-8.
39. Walker PR, Pandly S, Sikorska M. degradation of chromatin in apoptotic cells. Cell Death Differ 1995; 2: 97-104.
40. Luchetti F, Mariani AR, Columbaro M, et al. Apoptotic pathways depend on the target enzymatic activity and not on the triggering agent. Scanning 1998; 21: 29-35.
41. Nair J, Traganos F, Tse-Dinh YC. Differential effect of camptothecin treatment on topoisomerase II alpha expression in ML-1 and HL-60 leukemia cell lines. Anticancer Res 2000; 20: 4183-8.
42. Dynlacht JR, Earles M, Henthorn J, Seno JD. Different patterns of DNA fragmentation and degradation of nuclear matrix proteins during apoptosis induced by radiation, hyperthermia or etoposide. Radiat Res 2000; 154: 515-30.
43. Gazzanelli G, Luchetti F, Burattini S, Mannello F, Falcieri E, Papa S. Matrix metalloproteinases expression in HL-60 promyelocytic leukemia cells during apoptosis. Apoptosis 2000; 5: 165-72.
44. Renò F, Tontini A, Burattini S, Papa S, Falcieri E, Tarzia G. Mimosine induces apoptosis in the HL60 human tumor cell line. Apoptosis 1999; 4: 469-77.
45. Roth KA, D'Sa C. Apoptosis and brain development. Ment Retard Dev Disabil Res Rev 2001; 7: 261-6.
46. Falcieri E, Martelli AM, Bareggi R, Cataldi A., Cocco L. The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in Molt-4 cells without concomitant DNA fragmentation. Biochem Biophys Res Comm 1993; 193: 19-25.
47. Plozaj T, Motyl T, Zimowska W, Skierski J, Zwierzchowski L. Inhibition of ornithine decarboxylase by alpha-difluoromethylornithine induces apoptosis of HC11 mouse mammary epithelial cells. Amino Acids 2000; 19: 483-96.
48. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: Molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001; 58: 244-58.
49. Alvarez MG, Marty C, Mori G, Rivarola V. Effects of alpha- difluoromethylornitine on the Fas expression and apoptosis in Hep-2 cells. Biocell 2000; 24: 213-6.